Bristow MR - Search Results

1

Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy.

Sumner AD, Boehmer JP, Saxon LA, Carson P, Feldman AM, Galle E, Bristow MR. Sumner AD, et al. Among authors: bristow mr. Congest Heart Fail. 2009 Jul-Aug;15(4):159-64. doi: 10.1111/j.1751-7133.2009.00057.x. Congest Heart Fail. 2009. PMID: 19627288 Free article. Clinical Trial.

2

Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease.

Bristow MR, Feldman AM. Bristow MR, et al. Basic Res Cardiol. 1992;87 Suppl 1:15-35. doi: 10.1007/978-3-642-72474-9_2. Basic Res Cardiol. 1992. PMID: 1323259 Review.

3

Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction.

Feldman AM, Ray PE, Bristow MR. Feldman AM, et al. Among authors: bristow mr. J Mol Cell Cardiol. 1991 Dec;23(12):1355-8. doi: 10.1016/0022-2828(91)90182-l. J Mol Cell Cardiol. 1991. PMID: 1811054 Free article.

4

A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.

Hershberger RE, Feldman AM, Bristow MR. Hershberger RE, et al. Among authors: bristow mr. Circulation. 1991 Apr;83(4):1343-51. doi: 10.1161/01.cir.83.4.1343. Circulation. 1991. PMID: 1901530

5

The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy.

Feldman AM, Bristow MR. Feldman AM, et al. Among authors: bristow mr. Cardiology. 1990;77 Suppl 1:1-32. doi: 10.1159/000174645. Cardiology. 1990. PMID: 1970755 Review. No abstract available.

6

Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. Bristow MR, et al. Circulation. 1990 Aug;82(2 Suppl):I12-25. Circulation. 1990. PMID: 2164894 Review.

7

Altered expression of alpha-subunits of G proteins in failing human hearts.

Feldman AM, Cates AE, Bristow MR, Van Dop C. Feldman AM, et al. Among authors: bristow mr. J Mol Cell Cardiol. 1989 Apr;21(4):359-65. doi: 10.1016/0022-2828(89)90646-9. J Mol Cell Cardiol. 1989. PMID: 2501499

8

The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure.

Bristow MR, Port JD, Hershberger RE, Gilbert EM, Feldman AM. Bristow MR, et al. Eur Heart J. 1989 Jun;10 Suppl B:45-54. doi: 10.1093/eurheartj/10.suppl_b.45. Eur Heart J. 1989. PMID: 2572420 Review.

9

Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Bristow MR, et al. J Clin Invest. 1993 Dec;92(6):2737-45. doi: 10.1172/JCI116891. J Clin Invest. 1993. PMID: 8254027 Free PMC article.

10

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, et al. Feldman AM, et al. Among authors: bristow mr. N Engl J Med. 1993 Jul 15;329(3):149-55. doi: 10.1056/NEJM199307153290301. N Engl J Med. 1993. PMID: 8515787 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters